Mouse models of SLE support the concept that the decrease of IL-2 level can significantly inhibit the proliferation and differentiation of Treg cells in SLE patients, resulting in the imbalance of immune response and the development of SLE (11). The gene discussed is IL2; the disease is systemic lupus erythematosus.